Study reveals TWEAK-Fn14 as key drug target
Sunday, November 10, 2013 - 16:30
in Health & Medicine
A cellular pathway interaction known as TWEAK-Fn14, often associated with repair of acute injuries, also is a viable target for drug therapy that could prevent the spread of cancer, especially brain cancer, according to a study.